We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Aditxt Inc is a life sciences company which focuses on prolong life and enhance life quality of transplanted patients. The firm develop products designed to induce tolerance to transplanted organs. The firm's immunosuppressive (anti-rejection) drugs has made possible life-saving organ transplantatio... Aditxt Inc is a life sciences company which focuses on prolong life and enhance life quality of transplanted patients. The firm develop products designed to induce tolerance to transplanted organs. The firm's immunosuppressive (anti-rejection) drugs has made possible life-saving organ transplantation procedures as these drugs prevent or delay organ rejection. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) which utilizes tolerogenic approach that utilizes the body's natural process of cell death, to deliver a modified antigen that signals the immune system to become tolerant to transplanted tissues. Show more
Aditxt, Inc. (βAditxtβ βCompanyβ) (NASDAQ: ADTX), an innovation platform dedicated to accelerating promising health innovations, today announced the hosting of an update and Q&A session with...
Aditxt, Inc. (βAditxtβ ) (NASDAQ: ADTX), an innovation platform dedicated to accelerating promising health innovations, and Evofem Biosciences, Inc. (βEvofemβ) (OTCQB: EVFM), a pioneer in women's...
Acquisition target Evofem reported revenue of $7.8 million for the six months ended June 30, 2024 Acquisition target Appili has received approximately $6.0 million of the total $14.0 million to...
Aditxt, Inc. (NASDAQ: ADTX) (βAditxtβ or the βCompanyβ), an innovation platform dedicated to accelerating promising health innovations, announced today that it will effect a 1-for-40 reverse...
Companies Targeting Closing in Fourth Quarter of 2024 Aditxt, Inc. (NASDAQ: ADTX) (βAditxtβ or the βCompanyβ), an innovation platform dedicated to accelerating promising health innovations...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.89 | -42.5837320574 | 2.09 | 3.1 | 1.17 | 11392797 | 1.58519936 | CS |
4 | 0.71 | 144.897959184 | 0.49 | 5.12 | 0.0915 | 7307668 | 0.77902376 | CS |
12 | -0.84 | -41.1764705882 | 2.04 | 5.12 | 0.0915 | 4599835 | 1.00246588 | CS |
26 | -2.0177 | -62.7062808839 | 3.2177 | 5.12 | 0.0915 | 2382796 | 1.13537457 | CS |
52 | -10.31 | -89.574283232 | 11.51 | 13.7 | 0.0915 | 1615326 | 2.25016752 | CS |
156 | -69.6 | -98.3050847458 | 70.8 | 1139.6 | 0.0915 | 2186786 | 30.14731644 | CS |
260 | -210 | -99.4318181818 | 211.2 | 1139.6 | 0.0915 | 2254027 | 63.80257263 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions